These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 11888346)

  • 1. Progressive supranuclear palsy: clinical features, pathophysiology and management.
    Rajput A; Rajput AH
    Drugs Aging; 2001; 18(12):913-25. PubMed ID: 11888346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy.
    Ahmed Z; Josephs KA; Gonzalez J; DelleDonne A; Dickson DW
    Brain; 2008 Feb; 131(Pt 2):460-72. PubMed ID: 18158316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinicopathological study of vascular progressive supranuclear palsy: a multi-infarct disorder presenting as progressive supranuclear palsy.
    Josephs KA; Ishizawa T; Tsuboi Y; Cookson N; Dickson DW
    Arch Neurol; 2002 Oct; 59(10):1597-601. PubMed ID: 12374498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
    Jellinger KA
    Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathology of variants of progressive supranuclear palsy.
    Dickson DW; Ahmed Z; Algom AA; Tsuboi Y; Josephs KA
    Curr Opin Neurol; 2010 Aug; 23(4):394-400. PubMed ID: 20610990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive supranuclear palsy: new concepts.
    Barsottini OG; Felício AC; Aquino CC; Pedroso JL
    Arq Neuropsiquiatr; 2010 Dec; 68(6):938-46. PubMed ID: 21243256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An autopsied case of progressive supranuclear palsy presenting with slow progression and unusually prolonged disease duration].
    Iwasaki Y; Mori K; Ito M; Mimuro M; Yoshida M
    Rinsho Shinkeigaku; 2012; 52(3):156-60. PubMed ID: 22453039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progressive supranuclear palsy].
    Hasegawa K
    Rinsho Shinkeigaku; 1997 Dec; 37(12):1128-30. PubMed ID: 9577667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia.
    Josephs KA; Boeve BF; Duffy JR; Smith GE; Knopman DS; Parisi JE; Petersen RC; Dickson DW
    Neurocase; 2005 Aug; 11(4):283-96. PubMed ID: 16093229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An autopsy case of progressive supranuclear palsy with central pontine myelinolysis].
    Inagaki T; Hashizume Y; Nokura K; Yamamoto T; Niimi T; Mitake S; Ojika K; Yamamoto M
    Nihon Ronen Igakkai Zasshi; 1991 Mar; 28(2):226-31. PubMed ID: 1870289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnosis of progressive supranuclear palsy: current opinions and challenges.
    Ali F; Josephs K
    Expert Rev Neurother; 2018 Jul; 18(7):603-616. PubMed ID: 29902389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Review of Treatment Options for Progressive Supranuclear Palsy.
    Stamelou M; Höglinger G
    CNS Drugs; 2016 Jul; 30(7):629-36. PubMed ID: 27222018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Esophageal achalasia, sleep disorders and chorea in a tauopathy without ophthalmoplegia, parkinsonian syndrome, nor dementia (progressive supranuclear palsy?): clinicopathological study].
    Kaphan E; Pellissier JF; Rey M; Robert D; Auphan M; Ali Chérif A
    Rev Neurol (Paris); 2008 Apr; 164(4):377-83. PubMed ID: 18439931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tremor in progressive supranuclear palsy.
    Fujioka S; Algom AA; Murray ME; Sanchez-Contreras MY; Tacik P; Tsuboi Y; Van Gerpen JA; Uitti RJ; Rademakers R; Ross OA; Wszolek ZK; Dickson DW
    Parkinsonism Relat Disord; 2016 Jun; 27():93-7. PubMed ID: 27039056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinergic systems in progressive supranuclear palsy.
    Warren NM; Piggott MA; Perry EK; Burn DJ
    Brain; 2005 Feb; 128(Pt 2):239-49. PubMed ID: 15649952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progressive supranuclear palsy].
    Nakamura T; Imai H
    Nihon Rinsho; 1997 Jan; 55(1):127-30. PubMed ID: 9014435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case manifested overlapping neuropathologic features of both progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD)].
    Inagaki T; Seno HI; Iijima M; Nagai A; Bokura H; Kobayashi S; Wada M; Harada T
    No To Shinkei; 1998 Mar; 50(3):263-71. PubMed ID: 9566003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia.
    Kanazawa M; Tada M; Onodera O; Takahashi H; Nishizawa M; Shimohata T
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1149-51. PubMed ID: 23916652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive supranuclear palsy presenting as primary lateral sclerosis but lacking parkinsonism, gaze palsy, aphasia, or dementia.
    Nagao S; Yokota O; Nanba R; Takata H; Haraguchi T; Ishizu H; Ikeda C; Takeda N; Oshima E; Sakane K; Terada S; Ihara Y; Uchitomi Y
    J Neurol Sci; 2012 Dec; 323(1-2):147-53. PubMed ID: 23026537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early-stage progressive supranuclear palsy with degenerative lesions confined to the subthalamic nucleus and substantia nigra.
    Sakai K; Yamada M
    Neuropathology; 2011 Feb; 31(1):77-81. PubMed ID: 20573028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.